Kimberly Gray

919 citations

17 papers · 683 indexed · h-index 13

Impact in

Cell Biology top 10%
- Microtubule and mitosis dynamics
Oncology top 10%
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research

Papers in

Cell Biology 14
- Microtubule and mitosis dynamics 13
Oncology 8
- Cancer-related Molecular Pathways 8

Co-authors: Donna Carr Paul T. Kirschmeier Hena R. Ashar Linda James W. Robert Bishop Stuart Black Lydia Armstrong Andrea Basso
Journals: Bioorganic & Medicinal Chemistry Letters (4 papers)Biochemistry (2 papers)Molecular Cancer Therapeutics (1 paper)Bioorganic & Medicinal Chemistry (1 paper)FEBS Letters (1 paper)
Partner nations: United States United Kingdom

In The Last Decade

Kimberly Gray

16 papers receiving 663 citations

Peers

Countries citing papers authored by Kimberly Gray

Since Specialization

Citations

This map shows the geographic impact of Kimberly Gray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberly Gray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberly Gray more than expected).

Fields of papers citing papers by Kimberly Gray

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimberly Gray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberly Gray. The network helps show where Kimberly Gray may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Kimberly Gray, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kimberly Gray Line = papers co-authored together Kimberly Gray links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work
1	Discovery of novel spiro 1,3,4-thiadiazolines as potent, orally bioavailable and brain penetrant KSP inhibitors Bioorganic & Medicinal Chemistry ·Umar Faruk Mansoor, زهرة عبد محمد, Chaoyang Dai, Liping Yang, Dilrukshi Vitharana, Andrea Basso, Kimberly Gray, Huadong Tang, Ming Liu, Lianzhu Liang, Petersen, M. Arshad Siddiqui	2015	13
2	Synthesis and SAR studies of imidazo-[1,2-a]-pyrazine Aurora kinase inhibitors with improved off-target kinase selectivity Bioorganic & Medicinal Chemistry Letters ·Matthew E. Voss, Matthew P. Rainka, Mike Fleming, P. Joshi, David Belanger, M. Arshad Siddiqui, Alan Hruza, Johannes Voigt, Kimberly Gray, Andrea Basso	2012	9
3	SCH 1473759, a novel Aurora inhibitor, demonstrates enhanced anti-tumor activity in combination with taxanes and KSP inhibitors Cancer Chemotherapy and Pharmacology ·Andrea Basso, Ming Liu, Kimberly Gray, Seema Tevar, Suining Lee, Lianzhu Liang, A. S. Ponery, Elizabeth B. Smith, Frederick J. Monsma, BU Yu-wei, Yonglian Zhang, Angela D. Kerekes, Rizka Zamzani Ibrahim, Yushi Xiao, Jayaram R. Tagat, Daniel J. Hicklin, Paul T. Kirschmeier	2011	4
4	SCH 2047069, a Novel Oral Kinesin Spindle Protein Inhibitor, Shows Single-Agent Antitumor Activity and Enhances the Efficacy of Chemotherapeutics Molecular Cancer Therapeutics ·Andrea Basso, Ming Liu, Chaoyang Dai, Kimberly Gray, Holger Frentzel, Seema Tevar, Suining Lee, Lianzhu Liang, A. S. Ponery, Bohdan Yaremko, Elizabeth Smith, Huadong Tang, Payal R. Sheth, M. Arshad Siddiqui, Daniel J. Hicklin, Paul T. Kirschmeier	2010	17
5	Expression, purification, stability optimization and characterization of human Aurora B kinase domain from E. coli Archives of Biochemistry and Biophysics ·Payal R. Sheth, Lata Ramanathan, Jun Bum Lee, Andrea Basso, Dianah Barrett, Jia Zhao, Kimberly Gray, Yan‐Hui Liu, Rumin Zhang, Hung V. Le	2010	6
6	Discovery of orally bioavailable imidazo[1,2-a]pyrazine-based Aurora kinase inhibitors Bioorganic & Medicinal Chemistry Letters ·David Belanger, Michael Williams, Patrick J. Curran, Amit Kumar Mandal, Zhaoyang Meng, Matthew P. Rainka, BU Yu-wei, Neng‐Yang Shih, M. Arshad Siddiqui, Ming Liu, Seema Tevar, Suining Lee, Lianzhu Liang, Kimberly Gray, Bohdan Yaremko, J. Shawn Jones, Elizabeth B. Smith, D. B. Prelusky, Andrea Basso	2010	16
7	Bioisosteric approach to the discovery of imidazo[1,2-a]pyrazines as potent Aurora kinase inhibitors Bioorganic & Medicinal Chemistry Letters ·Zhaoyang Meng, Bheemashankar A. Kulkarni, Angela D. Kerekes, Amit Kumar Mandal, Rizka Zamzani Ibrahim, David Belanger, Sato Denise Maria Vecino, Andrea Basso, Seema Tevar, Kimberly Gray, J. Shawn Jones, Elizabeth B. Smith, Ronald J. Doll, M. Arshad Siddiqui	2010	12
8	Structural basis of CX-4945 binding to human protein kinase CK2 FEBS Letters ·Andrew D. Ferguson, Payal R. Sheth, Andrea Basso, Sunil Paliwal, Kimberly Gray, Thierry Fischmann, Hung V. Le	2010	99
9	Discovery of imidazo[1,2-a]pyrazine-based Aurora kinase inhibitors Bioorganic & Medicinal Chemistry Letters ·David Belanger, Patrick J. Curran, Alan Hruza, Johannes Voigt, Zhaoyang Meng, Amit Kumar Mandal, M. Arshad Siddiqui, Andrea Basso, Kimberly Gray	2010	34
10	Novel Benzimidazole Inhibitors Bind to a Unique Site in the Kinesin Spindle Protein Motor Domain Biochemistry ·Payal R. Sheth, Gerald W. Shipps, Wolfgang Seghezzi, Catherine K. Smith, Cheng‐Chi Chuang, Andrzej Ruszer, Andrea Basso, L.Z. Vilenchik, Kimberly Gray, D. Allen Annis, Elliott Nickbarg, Yao Ma, Brian R. Lahue, Ronald Herbst, Hung V. Le	2010	25
11	Abstract 1648: SCH 1473759, a novel aurora inhibitor, demonstrates enhanced antitumor activity in combination with taxanes and KSP inhibitors Cancer Research ·Andrea Basso, Kimberly Gray, Seema Tevar, О. В. Бродова, Suining Lee, Ming Liu, Elizabeth B. Smith, BU Yu-wei, L. Vanzetti, Ronald J. Doll, David Belanger, Arshad Siddiqui, Susana Pereira Bulas Cruz, Yushi Xiao, Rizka Zamzani Ibrahim, Jonna Behrends, Dan Hicklin, Paul T. Kirschmeier	2010	0
12	Aurora Kinase Inhibitors Based on the Imidazo[1,2-a]pyrazine Core: Fluorine and Deuterium Incorporation Improve Oral Absorption and Exposure Journal of Medicinal Chemistry ·Angela D. Kerekes, Rizka Zamzani Ibrahim, Ronald J. Doll, Jayaram R. Tagat, BU Yu-wei, Yushi Xiao, Yonglian Zhang, D. B. Prelusky, Seema Tevar, Kimberly Gray, Dawit Makonnen, Suining Lee, J. Shawn Jones, Ming Liu, Andrea Basso, Elizabeth B. Smith	2010	49
13	Thermodynamics of Nucleotide and Inhibitor Binding to Wild-Type and Ispinesib-Resistant Forms of Human Kinesin Spindle Protein Biochemistry ·Payal R. Sheth, Andrea Basso, José S. Duca, Charles A. Lesburg, Gilmara de, Kimberly Gray, Holger Frentzel, Anthony Mannarino, Andrew Prongay, Hung V. Le	2009	19
14	Expression and purification of phosphorylated and non-phosphorylated human MEK1 Protein Expression and Purification ·Catherine K. Smith, Donna Carr, Todd Mayhood, Weihong Jin, Kimberly Gray, William T. Windsor	2006	13
15	The Farnesyl Transferase Inhibitor SCH 66336 Induces a G2 → M or G1 Pause in Sensitive Human Tumor Cell Lines Experimental Cell Research ·Hena R. Ashar, Linda James, Kimberly Gray, Donna Carr, Исаев Юсуп Тожимаматович, Eugene Maxwell, Stuart Black, Lydia Armstrong, Ronald J. Doll, Arthur G. Taveras, W. Robert Bishop, Paul T. Kirschmeier	2001	92
16	Farnesyl Transferase Inhibitors Block the Farnesylation of CENP-E and CENP-F and Alter the Association of CENP-E with the Microtubules Journal of Biological Chemistry ·Hena R. Ashar, Linda James, Kimberly Gray, Donna Carr, Stuart Black, Lydia Armstrong, W. Robert Bishop, Paul T. Kirschmeier	2000	261
17	Analysis of Mutations within the Cytoplasmic Domain of the Moloney Murine Leukemia Virus Transmembrane Protein Virology ·峻瑩裴, Kimberly Gray, Monica J. Roth	1997	14

About Kimberly Gray

Kimberly Gray is a scholar working on Cell Biology, Oncology, Molecular Biology, Virology and Biochemistry, having authored 17 papers that have together received 683 indexed citations. Recurring topics across this work include Microtubule and mitosis dynamics (13 papers), Cancer-related Molecular Pathways (8 papers), Photosynthetic Processes and Mechanisms (5 papers), Cancer therapeutics and mechanisms (3 papers), Ubiquitin and proteasome pathways (3 papers), Protein Kinase Regulation and GTPase Signaling (2 papers), Melanoma and MAPK Pathways (2 papers) and Amino Acid Enzymes and Metabolism (1 paper). The work is most often cited by research in Cell Biology (167 citations), Oncology (255 citations), Molecular Biology (478 citations), Hematology (72 citations) and Organic Chemistry (108 citations). Kimberly Gray has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Donna Carr, Paul T. Kirschmeier, Hena R. Ashar, Linda James, W. Robert Bishop, Stuart Black, Lydia Armstrong, Andrea Basso, Payal R. Sheth and Hung V. Le. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Biochemistry, Molecular Cancer Therapeutics, Bioorganic & Medicinal Chemistry and FEBS Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact